Opendata, web and dolomites

Targeting TopoII SIGNED

Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward therational design of novel anticancer drugs

Total Cost €


EC-Contrib. €






 Targeting TopoII project word cloud

Explore the words cloud of the Targeting TopoII project. It provides you a very rough idea of what is the project "Targeting TopoII" about.

mm    metalloenzymes    dna    structural    topology    reaction    active    recombination    dynamics    md    catalytic    proposer    efficiency    boosting    soon    completing    clinical    resolution    biophysical    docking    inhibitors    basis    urgently    antibiotics    enhanced    ray    sampling    metal    insights    ions    site    strands    inhibitory    chances    molecular    drug    group    coupled    structures    hybrid    repair    qm    toward    elucidate    anticancer    regulating    clarify    first    resistance    cleave    data    techniques    pocket    showed    topoisomerase    decipher    catalysis    quantum    independent    back    ion    integrate    topoii    building    either    replication    zn    mechanistic    seek    energy    multiple    connecting    drugs    reactivity    relegate    discovery    mechanism    enzymatic    validated    bound    mechanics    computational    transcription    free    potent    simulations    reactants    establishing    depict    mg    unified    clear    skill    aided    secondly    type    estimates    permits   

Project "Targeting TopoII" data sheet

The following table provides information about the project.


Organization address
address: VIA MOREGO 30
city: GENOVA
postcode: 16163

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website
 Total cost 180˙277 €
 EC max contribution 180˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-11-06   to  2019-11-05


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Type II topoisomerase (TopoII) metalloenzymes are crucial in regulating DNA topology in replication, transcription, recombination, and repair processes. TopoII is thus a validated target for clinical antibiotics and anticancer drugs. Recent high-resolution X-ray structures of the TopoII/DNA complex showed multiple metal ions bound to the TopoII active site. On the basis of these novel findings, a unified two-metal-ion reaction mechanism for TopoII catalysis has been proposed. However, it is still not clear how this Mg-aided two-metal-ion mechanism permits TopoII to cleave and relegate back DNA strands. Building on our previous studies on metalloenzymes, we seek here to clarify TopoII’s two-metal-aided enzymatic mechanism and identify novel TopoII inhibitors, thus completing the proposer’s computational skill set, boosting her chances of establishing and leading soon an independent computational group. We propose two objectives: First, we will depict the reaction path connecting the enzymatic reactants and products in TopoII. We will achieve this using state-of-the-art computational methodologies such as molecular dynamics (MD) and hybrid quantum mechanics/molecular mechanics (QM/MM) simulations coupled to enhanced sampling techniques for free-energy estimates. We will thus elucidate the metal ion dynamics in TopoII catalysis, together with the metal-induced structural changes that affect the reactivity and efficiency of TopoII catalysis. Importantly, we will investigate TopoII catalysis in the presence of either the catalytic Mg or inhibitory Zn ions in the catalytic pocket. Secondly, we will integrate mechanistic insights on TopoII catalysis with the recent structural and biophysical data on TopoII to decipher drug resistance and identify new TopoII inhibitors. To this end, docking and MD simulations will be used to facilitate the discovery of potent TopoII inhibitors as a first step toward more effective anticancer drugs and new, urgently needed antibiotics.


year authors and title journal last update
List of publications.
2018 Alexandria A. Oviatt, Jissy A. Kuriappan, Elirosa Minniti, Kendra R. Vann, Princess Onuorah, Anna Minarini, Marco De Vivo, Neil Osheroff
Polyamine-containing etoposide derivatives as poisons of human type II topoisomerases: Differential effects on topoisomerase IIα and IIβ
published pages: 2961-2968, ISSN: 0960-894X, DOI: 10.1016/j.bmcl.2018.07.010
Bioorganic & Medicinal Chemistry Letters 28/17 2020-04-08
2019 Jissy A. Kuriappan, Neil Osheroff, Marco De Vivo
Smoothed Potential MD Simulations for Dissociation Kinetics of Etoposide To Unravel Isoform Specificity in Targeting Human Topoisomerase II
published pages: 4007-4017, ISSN: 1549-9596, DOI: 10.1021/acs.jcim.9b00605
Journal of Chemical Information and Modeling 59/9 2020-04-08

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TARGETING TOPOII" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TARGETING TOPOII" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

TIPTOP (2019)

Tensoring Positive Maps on Operator Structures

Read More  

NPsVLCD (2019)

Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease

Read More  

MingleIFT (2020)

Multi-color and single-molecule fluorescence imaging of intraflagellar transport in the phasmid chemosensory cilia of C. Elegans

Read More